Filing Details
- Accession Number:
- 0001181431-11-054340
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2011-11-02 16:41:18
- Reporting Period:
- 2011-10-31
- Filing Date:
- 2011-11-02
- Accepted Time:
- 2011-11-02 16:41:18
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 891288 | Questcor Pharmaceuticals Inc | QCOR | Pharmaceutical Preparations (2834) | 330476164 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1378166 | David Young | 6011 University Blvd. Suite 260 Ellicott City MD 21043 | Chief Scientific Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2011-10-31 | 75,000 | $4.54 | 83,002 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2011-10-31 | 75,000 | $41.03 | 8,002 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2011-10-31 | 4,724 | $41.40 | 3,278 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2011-10-31 | 75,000 | $0.00 | 75,000 | $4.54 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 275,000 | 2019-10-29 | No | 4 | M | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.79-$41.53, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 1 of the Form 4.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.40-$41.43, inclusive. The reporting person undertakes to provide Questcor Pharmaceuticals, Inc., any security holder of Questcor Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this Footnote 2 of the Form 4.
- Non-Qualified Stock option granted under the Questcor Pharmaceuticals, Inc. 2006 Equity Incentive Award Plan on October 30, 2009.
- Of the total amount of shares underlying the option, 175,000 were vested and exercisable as of Octboer 30, 2011.
Billionaire Hedge Funds
